(Q48557675)

12 February 2018

title

Trigeminal ganglion elicited increases in nucleus trigeminal caudalis blood flow: a novel migraine model. (English)

1 reference

12 February 2018

1 reference

McCall RB

1

1 reference

12 February 2018

language of work or name

English

0 references

publication date

1 November 1997

1 reference

12 February 2018

published in

Brain Research

1 reference

12 February 2018

volume

775

1 reference

12 February 2018

page(s)

189-192

1 reference

12 February 2018

issue

1-2

1 reference

12 February 2018

The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura mater

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Rationale for the use of 5-HT1-like agonists in the treatment of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Preclinical Studies on the Anti-Migraine Drug, Sumatriptan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Variable participation of 5-HT1-like receptors and 5-HT2 receptors in serotonin-induced contraction of human isolated coronary arteries. 5-HT1-like receptors resemble cloned 5-HT1D beta receptors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Selective 5-HT1D alpha serotonin receptor gene expression in trigeminal ganglia: implications for antimigraine drug development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

Sumatriptan in the acute treatment of migraine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2900952-9

10.1016/S0006-8993(97)00952-9

7 January 2021

Identifiers

DOI

1 reference

12 February 2018

PubMed ID

9439842

1 reference

12 February 2018